Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace
NCT ID: NCT05110872
Last Updated: 2025-10-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
302 participants
INTERVENTIONAL
2021-07-26
2021-08-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers
NCT03897530
Evaluation of Cessation Preferences of Menthol Smoker
NCT02020005
COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM
NCT03306173
Smoking Cessation in Menthol Flavored Cigarette Smokers
NCT02342327
Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes
NCT03164668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Menthol cigarette smokers
Adults (21 y.o. and older) who smoke ate least 10 menthol cigarettes per day will be recruited.
Cigarette flavor restricted and e-cigarette flavor restricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor restricted and e-cigarette flavor unrestricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor restricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor unrestricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Non-menthol cigarette smokers
Adults (21 y.o. and older) who smoke ate least 10 non-menthol cigarettes per day will be recruited.
Cigarette flavor restricted and e-cigarette flavor restricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor restricted and e-cigarette flavor unrestricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor restricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor unrestricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cigarette flavor restricted and e-cigarette flavor restricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor restricted and e-cigarette flavor unrestricted
1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor restricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Cigarette flavor unrestricted and e-cigarette flavor unrestricted
1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace
2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have smoked at least 100 cigarettes (lifetime), and
* are 21 years of age or older.
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
National Cancer Institute (NCI)
NIH
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberta Freitas-Lemos
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Warren K Bickel, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Fralin Biomedical Research Institute at VTC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fralin Biomedical Research Institute
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VT IRB# 20-827
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.